|
Oct 11
|
CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
|
|
Oct 9
|
CareDx Inc (CDNA) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Positive Adjusted ...
|
|
Oct 9
|
CareDx Appoints Jing Huang Chief Data and AI Officer
|
|
Oct 8
|
CareDx to Host Investor Day on October 15, 2024
|
|
Oct 8
|
Sector Update: Health Care Stocks Rise Late Afternoon
|
|
Oct 8
|
CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing
|
|
Jun 3
|
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
|
|
Jan 11
|
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
|
|
Jan 9
|
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
|
|
Dec 19
|
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
|
|
Dec 8
|
How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72%
|
|
Jul 18
|
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test
|